Historical record - last NADAC publication: 2/21/2024
Product Information
CLOBAZAM 20 MG TABLET is a generic product labeled by Taro Pharmaceuticals U.S.A. Inc., priced at $0.9377 per EA under NDC 51672420301. Its NADAC has been published 256 times since Apr 3, 2019.
Strength
20 mg/1
Manufacturer
Taro Pharmaceuticals U.S.A. Inc.NDC
51672420301
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
2/21/2024
Active Ingredients
CLOBAZAMApproval Type
Generic (ANDA)
FDA Application
ANDA209440On Market Since
10/22/2018
Pharmacological Classes
Price Statistics
The NADAC for CLOBAZAM 20 MG TABLET has been published 256 times since Apr 3, 2019, and over the history we have for it it has declined 35.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.9377 per EA |
|---|---|
| All-time high | $1.4581 (Jun 12, 2019) |
| All-time low | $0.4735 (Dec 22, 2021) |
| Median price | $0.7815 |
| Average price | $0.8276 |
| Largest weekly change | +78.0% (Aug 23, 2023) |
| Weeks tracked | 256 |
| Tracking since | Apr 3, 2019 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CLOBAZAM 20 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CLOBAZAM 20 MG TABLET, manufactured by Taro Pharmaceuticals U.S.A. Inc., is $0.9377 per EA (NDC 51672420301), effective Feb 21, 2024.
How has the price of CLOBAZAM 20 MG TABLET changed over time?
Over the history we have for it, the NADAC for CLOBAZAM 20 MG TABLET has declined 35.7%. It has been tracked across 256 weekly CMS publications since Apr 3, 2019.
What are the highest and lowest recorded NADAC prices for CLOBAZAM 20 MG TABLET?
Since Apr 3, 2019, the NADAC for CLOBAZAM 20 MG TABLET has ranged from a low of $0.4735 (Dec 22, 2021) to a high of $1.4581 (Jun 12, 2019), with a median of $0.7815 per EA.
Are there cheaper alternatives to CLOBAZAM 20 MG TABLET?
2 NADAC-published products share the same active ingredient, strength, and dosage form as CLOBAZAM 20 MG TABLET, but none are currently priced below it.
Who manufactures CLOBAZAM 20 MG TABLET?
CLOBAZAM 20 MG TABLET (NDC 51672420301) is labeled by Taro Pharmaceuticals U.S.A. Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification